A. Larkin
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cytokine Signaling Pathways and Interactions
-
- NF-κB Signaling Pathways
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 6
- HER2/EGFR in Cancer Research 2
-
- Viral Infectious Diseases and Gene Expression in Insects 1
- Protein purification and stability 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Catherine A. Andrews (1 shared paper)Donna J. Thuerauf (1 shared paper)Christopher C. Glembotski (1 shared paper)Patrick M. McDonough (1 shared paper)Martin Clynes (10 shared papers)Susan Kennedy (6 shared papers)Lorraine O’Driscoll (7 shared papers)John Crown (4 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Clinical Pathology (1 paper)Journal of Immunological Methods (1 paper)British Journal of Cancer (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- IrelandUnited StatesNetherlands
In The Last Decade
A. Larkin
12 papers receiving 570 citations
Peers
Comparison fields: 5 of 86
- Oncology 208
- Cancer Research 95
- Immunology 102
- Molecular Biology 262
- Toxicology 11
Countries citing papers authored by A. Larkin
This map shows the geographic impact of A. Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Larkin more than expected).
Fields of papers citing papers by A. Larkin
This network shows the impact of papers produced by A. Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Larkin. The network helps show where A. Larkin may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Larkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 309 | |
| 2 | 2006 | 53 | |
| 3 | MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma. | 2007 | 53 |
| 4 | MDR1/P-glycoprotein and MRP-1 mRNA and protein expression in non-small cell lung cancer. | 2007 | 36 |
| 5 | 2010 | 32 | |
| 6 | 1997 | 28 | |
| 7 | Expression and prognostic relevance of Mcl-1 in breast cancer. | 2004 | 21 |
| 8 | 1997 | 18 | |
| 9 | 2002 | 14 | |
| 10 | 1999 | 8 | |
| 11 | 2001 | 7 | |
| 12 | 2010 | 1 | |
| 13 | 2011 | 0 |
About A. Larkin
A. Larkin is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Surgery and Epidemiology, having authored 13 papers that have together received 580 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), HER2/EGFR in Cancer Research (2 papers), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Protein purification and stability (1 paper), NF-κB Signaling Pathways (1 paper), Click Chemistry and Applications (1 paper), Polymer Surface Interaction Studies (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Oncology (208 citations), Cancer Research (95 citations), Immunology (102 citations), Molecular Biology (262 citations) and Toxicology (11 citations). A. Larkin has collaborated with scholars based in Ireland, United States and Netherlands. Frequent co-authors include Catherine A. Andrews, Donna J. Thuerauf, Christopher C. Glembotski, Patrick M. McDonough, Martin Clynes, Susan Kennedy, Lorraine O’Driscoll, John Crown, Robert O’Connor and E Morán. Their work appears in journals such as Journal of Clinical Oncology, Journal of Clinical Pathology, Journal of Immunological Methods, British Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.